Immune checkpoint (ICP) molecules, including CTLA-4 and PD-1/PD-L1 impede T cells' anti-tumor activity through the transmission of inhibitory signals leading to downregulation in immune responses [65, 66]. This evidence concerns the gene PDCD1 and neoplasm.